Carmelo Gurnari(@CarmeloGurnari) 's Twitter Profileg
Carmelo Gurnari

@CarmeloGurnari

MD @ClevelandClinic @unitorvergata | Lymphoma survivor#Resilient | MDS/AML/APL/Bone marrow failure syndromes| Member @TheEBMT_Trainee | Opinions are my own

ID:1413489656927117312

calendar_today09-07-2021 13:26:24

3,2K Tweets

2,6K Followers

1,8K Following

Carmelo Gurnari(@CarmeloGurnari) 's Twitter Profile Photo

Finally out and kudos to Dr.Hussein Awada!! Collaboration dream team Cleveland Clinic We studied a cohort of 1507 patients undergoing aHSCT and 263 patients who developed tMN without aHSCT to determine clinico-molecular features unique to post-aHSCT tMN.

Finally out and kudos to Dr.Hussein Awada!! Collaboration dream team @ClevelandClinic We studied a cohort of 1507 patients undergoing aHSCT and 263 patients who developed tMN without aHSCT to determine clinico-molecular features unique to post-aHSCT tMN.
account_circle
Alberto Mussetti MD(@albertomussetti) 's Twitter Profile Photo

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia | New England Journal of Medicine nejm.org/doi/full/10.10…

account_circle
Prof Ciro Rinaldi(@tamaciro) 's Twitter Profile Photo

Clinical Research Team brings phase one trials to patients in Lincolnshire lincolnshireworld.com/news/clinical-…

account_circle
Hematopoiesis News(@Hema_News) 's Twitter Profile Photo

Congratulations to Drs. Hussein Awada, Carmelo Gurnari, and team on their recent Leukemia Journal study! 👏

📖 Here's the full study: go.nature.com/3wg0HOO
Follow the author's thread for research highlights. ✨

account_circle
The EBMT(@TheEBMT) 's Twitter Profile Photo

📰 At , Francesca Del Bufalo was honoured with the Jon J. van Rood Award 🏆 for the winning study: CART01 for Relapsed or Refractory High-Risk Neuroblastoma

Read her interview about the research, what initially sparked her interest, and more.⬇️🔍 Francesca del Bufalo

📰 At #EBMT24, Francesca Del Bufalo was honoured with the Jon J. van Rood Award 🏆 for the winning study: CART01 for Relapsed or Refractory High-Risk Neuroblastoma Read her interview about the research, what initially sparked her interest, and more.⬇️🔍 @Fra_delBufalo…
account_circle
Nico Gagelmann(@NicoGagelmann) 's Twitter Profile Photo

We will present the first comprehensive study comparing different ruxolitinib strategies in myelofibrosis undergoing transplant as oral at European Hematology Association by Kristin Rathje

See you in Madri❤️🇪🇸 YoungEHA

We will present the first comprehensive study comparing different ruxolitinib strategies in myelofibrosis undergoing transplant as oral at #EHA2024 @EHA_Hematology by @Kristin_Rathje #mpnsm See you in Madri❤️🇪🇸 @young_eha
account_circle
Kai Rejeski(@KRejeski) 's Twitter Profile Photo

Excited to see this paper out ! 🎉

Together with the wonderful Emily Liang we developed a fully automated approach to grade hematotoxicity (ICAHT) after CAR-T

Check out the link below ⤵️

nature.com/articles/s4140…

account_circle
Nana ETS(@Nana_ETS) 's Twitter Profile Photo

April 21 marks World Awareness Day for AML, Acute Myeloid Leukaemia, one of the most aggressive blood cancers. Come and see on nanaets.org what it's all about.

uniamomalattierare EURORDIS-Rare Diseases Europe

April 21 marks World Awareness Day for AML, Acute Myeloid Leukaemia, one of the most aggressive blood cancers. Come and see on nanaets.org what it's all about. #AML #BloodDisorder #HealthFacts @uniamofimronlus @eurordis #KnowAML
account_circle